Shots: Celenex (a Nationwide Children Hospital spin out) to receive an upfront of $100M cash, development milestones up to $15M, and may be eligible for up to $75M tiered sales […]readmore
Tags : Amicus Therapeutics
Shots: The approval is based on P-III FACET or Study 011 results assessing Galafold (150mg) in patient with Fabry Disease, evaluating its safety and efficacy The FACET or Study 011 […]readmore